Guideline
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up - European Society for Medical Oncology (ESMO)
These updated ESMO Clinical Practice Guidelines provide key recommendations on the management of chronic lymphocytic leukaemia (CLL).
Authorship includes a multidisciplinary group of experts from different institutions and countries in Europe.
Recommendations are provided, including levels of evidence and grades of recommendation where applicable.
Prognosis and treatment decisions in CLL depend on genetic and clinical factors including age, stage and comorbidities.
Therapies targeting B-cell-receptor pathway or defect mechanism of apoptosis induce long lasting remissions.